Business Description
Guided Therapeutics Inc
NAICS : 334510
SIC : 3845
ISIN : US40171F5017
Total Employee Number:
3Description
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | -3.23 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -1.1 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -144.33 | |||||
Beneish M-Score | 673.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.3 | |||||
3-Year EPS without NRI Growth Rate | 36.4 | |||||
3-Year FCF Growth Rate | 32.7 | |||||
3-Year Book Growth Rate | 10.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.6 | |||||
9-Day RSI | 43.14 | |||||
14-Day RSI | 48.69 | |||||
3-1 Month Momentum % | 30 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | 10.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.15 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 1021.25 | |||||
Days Sales Outstanding | 2.28 | |||||
Days Payable | 4359.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21 | |||||
Shareholder Yield % | -1.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.58 | |||||
Operating Margin % | -294.65 | |||||
Net Margin % | -426.47 | |||||
EBITDA Margin % | -331.68 | |||||
FCF Margin % | -176.53 | |||||
OCF Margin % | -176.53 | |||||
ROA % | -285.03 | |||||
ROIC % | -60.31 | |||||
3-Year ROIIC % | 46.79 | |||||
ROC (Joel Greenblatt) % | -772.14 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 28.89 | |||||
EV-to-EBIT | -10.65 | |||||
EV-to-EBITDA | -11.1 | |||||
EV-to-Revenue | 36.81 | |||||
EV-to-FCF | -20.85 | |||||
Earnings Yield (Greenblatt) % | -9.39 | |||||
FCF Yield % | -5.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GTHP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guided Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.767 | ||
| EPS (TTM) ($) | -0.04 | ||
| Beta | 1.3276 | ||
| 3-Year Sharpe Ratio | 0.35 | ||
| 3-Year Sortino Ratio | 0.8 | ||
| Volatility % | 135.09 | ||
| 14-Day RSI | 48.69 | ||
| 14-Day ATR ($) | 0.018259 | ||
| 20-Day SMA ($) | 0.270559 | ||
| 12-1 Month Momentum % | 10.64 | ||
| 52-Week Range ($) | 0.1231 - 0.54 | ||
| Shares Outstanding (Mil) | 96.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guided Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guided Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.00125:1 Stock Split | 2019-03-29 | 0.16 (+0.00%) | ||
| 0.00125:1 Stock Split | 2016-11-07 | 1,344.00 (-46.84%) | ||
| 0.01:1 Stock Split | 2016-02-24 | 352,564.10 (-26.67%) |
Show
Entries
Guided Therapeutics Inc Frequently Asked Questions
What is Guided Therapeutics Inc(GTHP)'s stock price today?
The current price of GTHP is $0.26. The 52 week high of GTHP is $0.54 and 52 week low is $0.12.
When is next earnings date of Guided Therapeutics Inc(GTHP)?
The next earnings date of Guided Therapeutics Inc(GTHP) is .
Does Guided Therapeutics Inc(GTHP) pay dividends? If so, how much?
Guided Therapeutics Inc(GTHP) does not pay dividend.
Guru Commentaries on OTCPK:GTHP
No articles.
Press Release
Articles on Guided Therapeutics Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers